Exagen Inc (XGN) — Cash Flow-to-Debt Ratio
Exagen Inc (XGN) has a Cash Flow-to-Debt Ratio of 0.07x as of September 2025, meaning its operating cash flow of $2.94 Million could theoretically repay 0% of its total liabilities ($44.69 Million) in one year. See Exagen Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Exagen Inc Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for Exagen Inc across 12 annual periods. Also explore XGN shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Exagen Inc (2012–2024)
Year-by-year debt coverage analysis for Exagen Inc. For market capitalisation and broader financial context, see Exagen Inc (XGN) total market value.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.38x | $-13.28 Million | $35.15 Million | ▲ +10.5% |
| 2023 | -0.42x | $-14.46 Million | $34.25 Million | ▲ +42.5% |
| 2022 | -0.73x | $-32.14 Million | $43.76 Million | ▼ -39.6% |
| 2021 | -0.53x | $-20.27 Million | $38.51 Million | ▼ -36.5% |
| 2020 | -0.39x | $-14.08 Million | $36.54 Million | ▼ -29.6% |
| 2019 | -0.30x | $-9.71 Million | $32.65 Million | ▼ -13.9% |
| 2018 | -0.26x | $-9.30 Million | $35.62 Million | ▲ +40.4% |
| 2017 | -0.44x | $-10.97 Million | $25.03 Million | ▼ -35.5% |
| 2015 | -0.32x | $-11.90 Million | $36.81 Million | ▲ +6.3% |
| 2014 | -0.35x | $-10.77 Million | $31.20 Million | ▲ +19.5% |
| 2013 | -0.43x | $-6.87 Million | $16.00 Million | ▲ +63.0% |
| 2012 | -1.16x | $-7.48 Million | $6.44 Million | — |